Shimizu Yuji, Sato Shimpei, Koyamatsu Jun, Yamanashi Hirotomo, Nagayoshi Mako, Kadota Koichiro, Kawashiri Shin-Ya, Maeda Takahiro
Department of Community Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Department of Cardiovascular Disease Prevention, Osaka Center for Cancer and Cardiovascular Disease Prevention, Osaka, Japan.
J Physiol Anthropol. 2017 Jun 15;36(1):26. doi: 10.1186/s40101-017-0143-9.
Although high-density lipoprotein-cholesterol (HDL) level is inversely correlated with cardiovascular events, HDL is also reported to be positively associated with hypertension, which is a known endothelial impairment factor. Since HDL mediates important protective actions on the vascular endothelium by increasing the number of circulating endothelial progenitor cells (CD34-positive cells), the level of circulating CD34-positive cells should influence the association between HDL and hypertension.
To investigate the association between HDL and hypertension in relation to the level of circulating CD34-positive cells, we conducted a cross-sectional study of 477 elderly men aged 60-69 years who participated in general health checkup.
HDL was found to be significantly positively associated with hypertension in subjects with a high level of circulating CD34-positive cells, while no significant association was observed for subjects with low circulating CD34-positive cells. Known cardiovascular risk factors adjusted odds (ORs) and 95% confidence intervals (CIs) of hypertension for increments of one standard deviation (SD) in HDL (13.8 mg/dL) were 1.44 (1.06, 1.96) for subjects with a high level of circulating CD34-positive cells and 0.87 (0.63, 1.19) for subjects with low circulating CD34-positive cells. We also revealed a significant association between HDL level and CD34-positive cell level on hypertension, with fully adjusted p values for the effect of this interaction on hypertension at 0.022.
Independent of known cardiovascular risk factors, HDL was found to be positively associated with hypertension in subjects with a high level of circulating CD34-positive cells but not for subjects with low circulating CD34-positive cells.
尽管高密度脂蛋白胆固醇(HDL)水平与心血管事件呈负相关,但也有报道称HDL与高血压呈正相关,而高血压是一种已知的内皮损伤因子。由于HDL通过增加循环内皮祖细胞(CD34阳性细胞)的数量对血管内皮发挥重要的保护作用,因此循环CD34阳性细胞的水平应会影响HDL与高血压之间的关联。
为了研究HDL与高血压之间的关联以及循环CD34阳性细胞水平的关系,我们对477名年龄在60 - 69岁参加一般健康体检的老年男性进行了横断面研究。
在循环CD34阳性细胞水平高的受试者中,发现HDL与高血压显著正相关,而在循环CD34阳性细胞水平低的受试者中未观察到显著关联。已知心血管危险因素调整后的HDL每增加一个标准差(SD,13.8mg/dL)时高血压的比值比(OR)和95%置信区间(CI),在循环CD34阳性细胞水平高的受试者中为1.44(1.06,1.96),在循环CD34阳性细胞水平低的受试者中为0.87(0.63,1.19)。我们还揭示了HDL水平与CD34阳性细胞水平对高血压的显著关联,这种相互作用对高血压影响的完全调整p值为0.022。
独立于已知的心血管危险因素,发现HDL在循环CD34阳性细胞水平高的受试者中与高血压正相关,但在循环CD34阳性细胞水平低的受试者中并非如此。